Lonza Confirms Interest in Acquiring Capsugel
By

By
Lonza confirms that it has “expressed a strong in interest” for a possible acquisition of Capsugel, a company that designs, develops, and manufactures dosage forms, according to a December 12,…

AstraZeneca Plans Job Cuts in US Commercial Business
By

By
AstraZeneca has announced that it will eliminate 700 positions across its US commercial business, including the company’s North American commercial headquarters, as part of its ongoing restructuring. The impacted positions…

Lonza Sells Belgium Peptides Biz to PolyPeptides Group
By

By
Lonza has agreed to sell its peptide business operations in Braine-l’Alleud, Belgium to the PolyPeptide Group, a Torrance, California-headquartered contract manufacturing organization. The acquisition expands the total manufacturing capacity and…

Mylan Plans Restructuring and Cuts in Global Workforce
By

By
Mylan has announced plans for restructuring programs in certain locations representing initial steps in a series of actions that are anticipated to further streamline its operations globally. The company anticipates that…

Cellca, Synpromics in Biologics Production Pact
By

By
Sartorius Stedim Cellca (Cellca), a Laupheim, Germany-based company specializing in mammalian cell-line and upstream process development, has formed a collaboration with Synpromics, an Edinburgh, UK-based synthetic promoter and gene control…

Shire Moves Forward with $400 Million Biomanufacturing Expansion
By

By
Editor’s note: this story was updated on December 8, 2016 to include further details and background. Shire has received formal planning permission from the Meath County Council for its $400…

Teva Appoints New President and CEO of Generics Group
By

By
Teva Pharmaceutical Industries has named Dipankar Bhattacharjee president and chief executive officer (CEO), Global Generic Medicines Group, effective on December 5, 2016. He succeeds Sigurdur Olafsson, who will step down…

Idifarma Expands Capsule-Filling Capability
By

By
Idifarma, a contract development and manufacturing organization, has expanded its GMP manufacturing offering with an investment in automatic capsule-filling equipment. The company acquired a Bosch GKF-702 capsule-filling machine, capable of…

MilliporeSigma Launches New Excipient
By

By
MilliporeSigma, the life-sciences business of Merck KGaA, has launched Parteck MXP, a polyvinyl alcohol-based excipient for enhancing the solubility of active pharmaceutical ingredients (APIs) with poor bioavailability. Parteck MXP excipient…

Aptar Pharma Nears Completion of Elastomer Component Expansion
By

By
Aptar Pharma has nearly completed its expansion at its Congers, New York manufacturing site, with the new space to be employed for injectable elastomeric component manufacturing. Final construction is planned…